A study found that the expression of PDL1 is up-regulated in the HCC cells of mice treated with c-Met inhibitors, which induces the functional inactivation of T-cells and enables HCC cells to escape from the killing of T-cells (Li et al., 2019). Here, MET is linked to hepatocellular carcinoma.